In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms

S Cankat, MU Demael, L Swadling - Cellular & molecular immunology, 2024 - nature.com
Members of the coronaviridae family are endemic to human populations and have caused
several epidemics and pandemics in recent history. In this review, we will discuss the …

Blood Biomarkers of Long COVID: A Systematic Review

C Thomas, MA Faghy, C Chidley, BE Phillips… - Molecular Diagnosis & …, 2024 - Springer
Background Long coronavirus disease (COVID; LC) affects millions of people worldwide.
The exact mechanisms which result in a broad, undulating and detrimental symptom profile …

Pathophysiological, immunological, and inflammatory features of long COVID

K Bohmwald, B Diethelm-Varela… - Frontiers in …, 2024 - frontiersin.org
The COVID-19 pandemic continues to cause severe global disruption, resulting in significant
excess mortality, overwhelming healthcare systems, and imposing substantial social and …

Long COVID: a new word for naming fibromyalgia?

X Mariette - Annals of the Rheumatic Diseases, 2024 - ard.bmj.com
Long COVID is the name given to a syndrome comprising a wide variety of symptoms
persisting more than 3 months after acute benign COVID-19, with a prevalence ranging from …

Cardiovascular dysautonomia in postacute sequelae of SARS‐CoV‐2 infection

M Ståhlberg, A Mahdi, M Johansson… - Journal of …, 2024 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) has led to a worldwide pandemic that
continues to transform but will not go away. Cardiovascular dysautonomia in postacute …

The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions

A Hromić-Jahjefendić, L Mahmutović, A Sezer… - Cytokine & Growth …, 2024 - Elsevier
Long COVID-19 affects a significant percentage of patients and is characterized by a wide
range of symptoms, including weariness and mental fog as well as emotional symptoms like …

Differences in the Clinical Manifestations and Host Immune Responses to SARS-CoV-2 Variants in Children Compared to Adults

S Demirhan, DL Goldman, BC Herold - Journal of Clinical Medicine, 2023 - mdpi.com
The COVID-19 pandemic challenged the medical field to rapidly identify and implement new
approaches to the diagnosis, treatment and prevention of SARS-CoV-2 infections. The …

COVID-19 in the initiation and progression of atherosclerosis: Pathophysiology during and beyond the acute phase

V Chidambaram, A Kumar, MI Sadaf, E Lu, SJ Al'Aref… - JACC: Advances, 2024 - jacc.org
The incidence of atherosclerotic cardiovascular disease is increasing globally, especially in
low-and middle-income countries, despite significant efforts to reduce traditional risk factors …

Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease

J Yan, CR Bangalore, N Nikouyan, S Appelberg… - Molecular Therapy, 2024 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific neutralizing
antibodies (NAbs) lack cross-reactivity between SARS-CoV species and variants and fail to …

Trajectories of Inflammatory Markers and Post–COVID-19 Cognitive Symptoms: A Secondary Analysis of the CONTAIN COVID-19 Randomized Trial

JA Frontera, RA Betensky, L Pirofski… - Neurology …, 2024 - AAN Enterprises
Background and Objectives Chronic systemic inflammation has been hypothesized to be a
mechanistic factor leading to post–acute cognitive dysfunction after COVID-19. However …